Megan Daly, Md
Clinical trials sponsored by Megan Daly, Md, explained in plain language.
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two drugs—TG4010 (a vaccine that helps the immune system attack cancer) and nivolumab (an immunotherapy that removes cancer's brakes on immune cells)—in 13 people with advanced non-small cell lung cancer who had already tried other treatments. T…
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 17, 2026 10:43 UTC
-
New combo therapy shows promise for inoperable lung cancer patients
Disease control CompletedThis early-stage study tested a combination of an immunotherapy drug (atezolizumab) and precise, high-dose radiation (SBRT) in 20 people with stage I non-small cell lung cancer who could not have surgery. The main goal was to find the safest dose of atezolizumab when given with r…
Phase: PHASE1 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 17, 2026 10:41 UTC